Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol inhalation solution for mucus-related symptoms in children with lower respiratory tract infection
CTR20190176Phase 3Active
- Sponsor
- 泰州锦鸿医药科技有限公司
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ambroxol in pulmonary infection, sponsored by 泰州锦鸿医药科技有限公司. Started Jan 2019; status: active.
02
Drugs
ambroxol
03
Conditions
pulmonary infection
Beyond the preview
Go deeper on CTR20190176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190176.